Joe Moonjely in Coralville, Iowa

Medical School: Sorry, his university is not listed
Graduation Year: 1992
The Primary Medical Specialty for Joe Moonjely is listed as: Internal Medicine
Approximate Years of Experience: 32
PAC (PECOS ID)#: 0042405607
NPI #: 1215021753
NPI Created On: 10/02/2006
NPI Last Updated Listed as: 04/12/2011
Primary Taxonomy Code: 207R00000X
License Number:
35090
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Medica Insurance Company
• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Hemoglobin a1c level
3. Blood test, clotting time
4. Vaccine for influenza for injection into muscle
5. Vaccine for influenza for administration into muscle, 0.5 ml dosage
6. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
7. Routine ekg using at least 12 leads including interpretation and report
8. Anti-clotting management for patient taking warfarin
9. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
10. New patient office or other outpatient visit, typically 30 minutes
11. New patient office or other outpatient visit, typically 45 minutes
12. Established patient office or other outpatient visit, typically 10 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Administration of influenza virus vaccine
16. Administration of pneumococcal vaccine
17. Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment
18. Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
19. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
20. Injection, denosumab, 1 mg